ALIM

Alimera Sciences (ALIM)

Alimera Sciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALIM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	06:06	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:ALIM	Alimera Sciences Inc
2024/05/15	06:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ALIM	Alimera Sciences Inc
2024/05/14	21:46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALIM	Alimera Sciences Inc
2024/05/14	20:30	GlobeNewswire Inc.	Alimera Sciences Reports First Quarter 2024 Results	NASDAQ:ALIM	Alimera Sciences Inc
2024/05/07	21:00	GlobeNewswire Inc.	Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences	NASDAQ:ALIM	Alimera Sciences Inc
2024/04/30	21:00	GlobeNewswire Inc.	Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update	NASDAQ:ALIM	Alimera Sciences Inc
2024/03/20	21:00	GlobeNewswire Inc.	Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ALIM	Alimera Sciences Inc
2024/03/19	21:00	GlobeNewswire Inc.	Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network	NASDAQ:ALIM	Alimera Sciences Inc
2024/03/09	07:23	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALIM	Alimera Sciences Inc
2024/03/07	22:32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALIM	Alimera Sciences Inc
2024/03/07	21:30	GlobeNewswire Inc.	Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/29	22:00	GlobeNewswire Inc.	Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/14	06:43	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/14	06:24	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/14	05:27	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/10	07:25	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/10	07:14	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/10	07:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALIM	Alimera Sciences Inc
2024/02/08	22:00	GlobeNewswire Inc.	The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN®	NASDAQ:ALIM	Alimera Sciences Inc
2024/01/12	02:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALIM	Alimera Sciences Inc
2024/01/05	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALIM	Alimera Sciences Inc
2024/01/05	06:02	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALIM	Alimera Sciences Inc
2024/01/05	06:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALIM	Alimera Sciences Inc
2024/01/04	22:00	GlobeNewswire Inc.	Alimera Completes Recruitment for the Synchronicity Study	NASDAQ:ALIM	Alimera Sciences Inc
2024/01/02	22:00	GlobeNewswire Inc.	Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ALIM	Alimera Sciences Inc
2023/12/14	07:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALIM	Alimera Sciences Inc
2023/12/14	07:19	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ALIM	Alimera Sciences Inc
2023/12/13	07:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ALIM	Alimera Sciences Inc
2023/12/12	21:30	GlobeNewswire Inc.	Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ALIM	Alimera Sciences Inc
2023/11/29	06:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ALIM	Alimera Sciences Inc